Vitexicarpin effects proliferation and apoptosis in mutated p53 breast cancer cell

National Medical Journal of China

Volumn 90, Issue 10, 2010, Pages 703-707

  Song, Yong Chun ^a   Zhang, Xi ^b   Lei, Guang Yan ^b   Dang, Cheng Xue ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NONE

Author keywords

Apoptosis; Breast neoplasms; C Myc protein; Genes, p53; Vitexicarpin

Indexed keywords

ANTIMITOTIC AGENT; CASTICIN; MYC PROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; FLAVONOID;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE MUTATION; NICK END LABELING; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; DRUG EFFECT; FEMALE; GENETICS; HUMAN; MUTATION; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FLAVONOIDS; HUMANS; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871463035     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.10.016     Document Type: Article

References (12)

1. 1996, 21: 167-168, 191.
2. 2005, 40: 27-31.
3. Haidara K, Zamir L, Shi Q W, et al. The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett, 2006, 242: 180-190.
4. Longley D B, Johnston P G. Molecular mechanisms of drug resistance. J Pathol, 2005, 205: 275-292.
5. Bush J A, Li G. Cancer chemoresistance: the relationship between p53 and multidrug transporters. Int J Cancer, 2002, 98: 323-330.
6. Widodo N, Kaur K, Shrestha B G, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res, 2007, 13: 2298-2306.
7. Fiala E S, Reddy B S, Weisburger J H. Naturally occurring anticarcinogenic substances in foodstuffs. Annu Rev Nutr, 1985, 5: 295-321.
8. Kobayakawa J, Sato-Nishimori F, Moriyasu M, et al. G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.). Cancer Lett, 2004, 208: 59-64.
9. 2007, 87: 2935-2937.
10. Railo M, Lundin J, Haglund C, et al. Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer. Tumour Biol, 2007, 28: 45-51.
11. Kitaura H, Shinshi M, Uchikoshi Y, et al. Reciprocal regulation via protein-protein interaction between c-Myc and p21 (cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem, 2000, 275: 10477-10483.
12. Le M G, Mathieu M C, Douc-Rasy S, et al. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Int J Cancer, 1999, 84: 562-567.